HCP preferences have rapidly shifted towards remote and hybrid engagement. Cultural transformation, data silo elimination, and cross-functional collaboration are key to meeting these new demands through a successful omnichannel transition.

Pharmaceutical companies are likely to go digital in the next three-to-four years even with return of in-person engagements

Pharma companies should zero in on commonalities between functions to achieve a genuine customer-centric omnichannel

The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams